Second Annual Companion Diagnostics

Companion diagnostics are a key component of personalized medicine. The current environment will be reviewed and analyzed with regard to reimbursement and regulation of companion diagnostics, and recent approvals will be examined by key players in the industry. Opportunities that apply companion diagnostic drugs to improve patient care will be identified. Furthermore, the steps for implementing clinical decision support will be outlined.